Skip to main content

Find Clinical Trials

Home
Conditions
Sexually Transmitted Diseases

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,127 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

NCT00071097

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Beverly Hills, California, United States

Long Beach, California, United States

View all 39 locations

View Trial Details

Completed

Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men

NCT00856323

Conditions: Amphetamine-Related Disorders, Blood-Borne Infections, Chemically-Induced Disorders, +16 more
Locations: Friends Community Center Los Angeles, California, United States

View Trial Details

Completed

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

NCT00719602

Conditions: Blood-Borne Infections, Coinfection, Communicable Diseases, +17 more
Locations: University of North Carolina Lilongwe (12001) Lilongwe, Malawi

Makerere University - JHU Research Collaboration (30293) Kampala, Uganda

George Clinic CRS (30273) Lusaka, Zambia

View Trial Details

Completed

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

NCT00693966

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

NCT00693615

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Not specified

View Trial Details

Completed

Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study

NCT01679964

Conditions: Adverse Drug Reaction, Blood-Borne Infections, Chemically-Induced Disorders, +16 more
Locations: E-Da Hospital Kaohsiung, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

China Medical University Hospital Taichung, Taiwan

National Cheng Kung University Hospital Tainan, Taiwan

View Trial Details

Completed

An HPV Vaccine Provider Intervention in Safety Net Clinics

NCT02808832

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: Meharry Medical College Nashville, Tennessee, United States

View Trial Details

Completed

Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir

NCT02097108

Conditions: Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +16 more
Locations: PMU Salzburg Salzburg, Austria

AKH Wien Vienna, Austria

Ottto Wagner Spital Vienna, Austria

View Trial Details

Completed

A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection

NCT02785289

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Geneva University Hospitals Geneva, Switzerland

View Trial Details

Completed

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

NCT00169494

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Koebenhavn NV, Denmark

GSK Investigational Site Odense C, Denmark

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

View all 17 locations

View Trial Details